72 related articles for article (PubMed ID: 6543137)
1. [Metoclopramide plasma levels following oral administration of high doses for prophylaxis of emesis in cytostatic therapy].
Vergin H; Köhler M; Senn HJ
Arzneimittelforschung; 1984; 34(11):1595-7. PubMed ID: 6543137
[TBL] [Abstract][Full Text] [Related]
2. Suitability of long-acting metoclopramide for prophylaxis of chemotherapy-induced delayed nausea and vomiting.
Wilder-Smith C; Schimke J; Vergin H; Senn HJ
Arzneimittelforschung; 1989 Nov; 39(11):1464-7. PubMed ID: 2619781
[TBL] [Abstract][Full Text] [Related]
3. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
4. [High dose metoclopramide during cancer chemotherapy. Phase II study in 80 consecutive patients].
Bui NB; Marit G; Albin H; Durand M; Mauriac L; Hoerni B
Bull Cancer; 1982; 69(4):330-5. PubMed ID: 7150789
[TBL] [Abstract][Full Text] [Related]
5. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
Support Care Cancer; 2000 May; 8(3):229-32. PubMed ID: 10789965
[TBL] [Abstract][Full Text] [Related]
6. Effective control of cisplatin induced emesis by combination drug regimen.
Misra R; Agarwal N
Indian J Cancer; 1994 Mar; 31(1):19-22. PubMed ID: 8063331
[TBL] [Abstract][Full Text] [Related]
7. [Nausea and vomiting in cytostatic therapy of melanoma patients with the use of metoclopramide and corticosteroid or ondansetron].
Czeglédi F; Baki M
Orv Hetil; 1994 Oct; 135(44):2415-9. PubMed ID: 7970661
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W
J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
[TBL] [Abstract][Full Text] [Related]
9. Dose-ranging antiemetic trial of high-dose oral metoclopramide.
Tyson LB; Gralla RJ; Kris MG; Young CW; Clark RA
Am J Clin Oncol; 1989 Jun; 12(3):239-43. PubMed ID: 2658539
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetics and bioequivalence of various oral formulations of metoclopramide].
Vergin H; Bishop-Freudling GB; Strobel K; Reeves DS
Arzneimittelforschung; 1983; 33(3):458-62. PubMed ID: 6683523
[TBL] [Abstract][Full Text] [Related]
11. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
[TBL] [Abstract][Full Text] [Related]
12. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
[TBL] [Abstract][Full Text] [Related]
13. Oral ondansetron for preventing nausea and vomiting.
Cooke CE; Mehra IV
Am J Hosp Pharm; 1994 Mar; 51(6):762-71. PubMed ID: 8010314
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of cytostatic-induced vomiting with high-dose metoclopramide].
Ell C; König HJ
Dtsch Med Wochenschr; 1983 Jun; 108(24):962. PubMed ID: 6851896
[No Abstract] [Full Text] [Related]
15. Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.
Chawla SP; Grunberg SM; Gralla RJ; Hesketh PJ; Rittenberg C; Elmer ME; Schmidt C; Taylor A; Carides AD; Evans JK; Horgan KJ
Cancer; 2003 May; 97(9):2290-300. PubMed ID: 12712486
[TBL] [Abstract][Full Text] [Related]
16. [Prevention of cytostatic-induced vomiting. High-dosage metoclopramide versus an antiemetic combination in a controlled comparison].
Ell C; König HJ; Gutmann W; Domschke S; Domschke W
Med Welt; 1983 Sep; 34(35):945-8. PubMed ID: 6355746
[No Abstract] [Full Text] [Related]
17. Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
Manusirivithaya S; Chareoniam V; Isariyodom P; Sungsab D
J Med Assoc Thai; 2001 Jul; 84(7):966-72. PubMed ID: 11759977
[TBL] [Abstract][Full Text] [Related]
18. Prevention of delayed emesis with metoclopramide and dexamethasone in patients receiving moderately emetogenic cytotoxic treatment.
Chiara S; Campora E; Simoni C; Confalonieri M; Psilogenis M; Rosso R
Anticancer Res; 1995; 15(4):1597-9. PubMed ID: 7654054
[TBL] [Abstract][Full Text] [Related]
19. The combination of metoclopramide, methylprednisolone and ondansetron against antiblastic-delayed emesis: a randomised phase II study.
Mustacchi G; Ceccherini R; Leita ML; Sandri P; Milani S; Carbonara T
Anticancer Res; 1997; 17(2B):1345-8. PubMed ID: 9137496
[TBL] [Abstract][Full Text] [Related]
20. Metoclopramide kinetics at high-dose infusion rates for prevention of cisplatin-induced emesis.
Saller R; Hellenbrecht D; Briemann L; Hellstern A; Hess H; Mitrou P; Hodgson M; Achtert G; Brockmann P; Hausleiter HJ
Clin Pharmacol Ther; 1985 Jan; 37(1):43-7. PubMed ID: 4038385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
